The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status

BACKGROUND: Current chemotherapy of human cancers focuses on the DNA damage pathway to induce a p53-mediated cellular response leading to either G1 arrest or apoptosis. However, genotoxic treatments may induce mutations and translocations that result in secondary malignancies or recurrent disease. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Turinetto, Valentina, Porcedda, Paola, Orlando, Luca, De Marchi, Mario, Amoroso, Antonio, Giachino, Claudia
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743708/
https://www.ncbi.nlm.nih.gov/pubmed/19674456
http://dx.doi.org/10.1186/1471-2407-9-281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743708/
https://www.ncbi.nlm.nih.gov/pubmed/19674456
http://dx.doi.org/10.1186/1471-2407-9-281

Ejemplares similares